Equity Research, Broker Reports, and media content on Destiny Pharma Plc

  • Access the latest forecasts, broker valuations, multiples, and video content from the city about Destiny Pharma Plc
  • See live updates from analysts, company announcements, and other news in a personalised/single dashboard

Destiny Pharma Plc

Company Profile

  • Personnel
  • Neil Clark, CEO
  • Nick Rodgers, Chairman

Research, Charts & Company Announcements

Research Tree provides access to ongoing research coverage, media content and regulatory news on Destiny Pharma Plc. We currently have 99 research reports from 5 professional analysts.

  • Open: 114p
  • Range Today: 0.00/0.00p
  • 52 Week: 60.0/250p
  • Daily Volume: 0.0k
  • Daily Liquidity: (0%)
  • # Shares: 59.9m
  • Market Cap: £67.9m
  • Latest PE (hist):
  • Div Yield:
Date Source Announcement
15Nov21 14:26 RNS Destiny Pharma PLC - Directorate Change
04Nov21 07:00 RNS Destiny Pharma PLC - SAB Member Prof. Gerding is Keynote at C.diff Conf
18Oct21 07:00 RNS Destiny Pharma PLC - Study gives strong support for potential of XF-73
27Sep21 15:18 RNS Destiny Pharma PLC - Director/PDMR Shareholding
27Sep21 07:00 RNS Destiny Pharma PLC - Expansion of clinical pipeline
09Sep21 07:00 RNS Destiny Pharma PLC - Interim results for six months ended 30 June 2021
23Aug21 07:00 RNS Destiny Pharma PLC - Notice of Interim Results
  • Frequency of research reports


  • Research reports on

    Destiny Pharma Plc

  • Providers covering

    Destiny Pharma Plc